======= CAPN10 ======= == Gene Information == * **Official Symbol**: CAPN10 * **Official Name**: calpain 10 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11132|11132]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9HC96|Q9HC96]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CAPN10&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CAPN10|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605286|Open OMIM]] == Function Summary == * **Entrez Summary**: Calpains represent a ubiquitous, well-conserved family of calcium-dependent cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large catalytic subunit has four domains: domain I, the N-terminal regulatory domain that is processed upon calpain activation; domain II, the protease domain; domain III, a linker domain of unknown function; and domain IV, the calmodulin-like calcium-binding domain. This gene encodes a large subunit. It is an atypical calpain in that it lacks the calmodulin-like calcium-binding domain and instead has a divergent C-terminal domain. It is similar in organization to calpains 5 and 6. This gene is associated with type 2 or non-insulin-dependent diabetes mellitus (NIDDM), and is located within the NIDDM1 region. Multiple alternative transcript variants have been described for this gene. [provided by RefSeq, Sep 2010]. * **UniProt Summary**: N/A |Calpain III| |Peptidase C2| |type B pancreatic cell apoptotic process| |positive regulation of type B pancreatic cell apoptotic process| |regulation of type B pancreatic cell apoptotic process| |calcium-dependent cysteine-type endopeptidase activity| |cellular component disassembly involved in execution phase of apoptosis| |epithelial cell apoptotic process| |positive regulation of epithelial cell apoptotic process| |positive regulation of glucose import| |positive regulation of glucose transmembrane transport| |execution phase of apoptosis| |regulation of glucose import| |SNARE binding| |actin cytoskeleton reorganization| |positive regulation of insulin secretion| |regulation of glucose transmembrane transport| |cytoskeletal protein binding| |regulation of epithelial cell apoptotic process| |positive regulation of peptide hormone secretion| |positive regulation of hormone secretion| |cellular response to insulin stimulus| |regulation of insulin secretion| |positive regulation of transmembrane transport| |positive regulation of intracellular transport| |regulation of peptide hormone secretion| |response to insulin| |cellular response to peptide hormone stimulus| |regulation of hormone secretion| |positive regulation of protein secretion| |positive regulation of peptide secretion| |cellular response to peptide| |regulation of intracellular transport| |response to peptide hormone| |cellular component disassembly| |positive regulation of secretion by cell| |positive regulation of protein transport| |positive regulation of secretion| |positive regulation of establishment of protein localization| |regulation of protein secretion| |response to peptide| |actin cytoskeleton organization| |regulation of peptide secretion| |regulation of hormone levels| |regulation of transmembrane transport| |actin filament-based process| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |cellular response to nitrogen compound| |positive regulation of cell death| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of secretion| |response to hormone| |regulation of cellular localization| |apoptotic process| |positive regulation of transport| |response to organonitrogen compound| |regulation of protein localization| |programmed cell death| |cellular response to oxygen-containing compound| |response to nitrogen compound| |cell death| |cytoskeleton organization| |cellular response to endogenous stimulus| |mitochondrion| |proteolysis| |response to endogenous stimulus| |regulation of apoptotic process| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of cell death| |positive regulation of cell communication| |positive regulation of signaling| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11807 * **Expression level (log2 read counts)**: 5.24 {{:chemogenomics:nalm6 dist.png?nolink |}}